Poliovirus vaccine inactivated paediatric (GlaxoSmithKline)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePoliovirus vaccine inactivated paediatric (GlaxoSmithKline)
Drug Alias NameIPV vaccine - GlaxoSmithKlinePoliorix
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitis
Global Approved IndicationsPoliomyelitis
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2007/07/01
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsPoliomyelitis
Inactive IndicationsN/A

Other Information

ATC CodeJ07BF
Related LinksN/A